首页> 外文期刊>Advanced functional materials >Cuproptosis-Driven Enhancement of Thermotherapy by Sequentially Response Cu_(2-x)Se via Copper Chemical Transition
【24h】

Cuproptosis-Driven Enhancement of Thermotherapy by Sequentially Response Cu_(2-x)Se via Copper Chemical Transition

机译:Cuproptosis-Driven Enhancement of Thermotherapy by Sequentially Response Cu_(2-x)Se via Copper Chemical Transition

获取原文
获取原文并翻译 | 示例
           

摘要

Activation of cuproptosis pathway has been reported to hold great potentialin the application of tumor treatment. But the efficacy of cuproptosis seriouslylimited by the insufficient accumulation in the tumor sites. Therefore,herein based on the strong stabilization effects of the metalloid elementselenium (Se) on copper (Cu), a photothermic Cu_(2-x)Se nanoparticle encapsulatedwith bioresponsive dimethyl maleic anhydride (DMMA@Cu_(2-x)Se) as acopper-carrier to improve the copper accumulation in tumor is constructed,thus achieving cuproptosis-driven enhancement of thermotherapy. Thisnanosystem exhibits the enhancement of tumor cellular uptake by a weakacid-triggered charge-switching ability. Next step, the exposed Cu_(2-x)Se isoxidized and releases divalent copper by high-level oxide. Then, the abundantcopper induces more dihydrolipoamide S-acetyltransferase oligomerizationto down-regulate FDX1 and tricarboxylic acid cycle-related proteins, whichleads to inhibiting aerobic respiration. Cuproptosis-induced mitochondrialdamage further improves thermotherapy by up-regulating reactive oxygenspecies (ROS). In addition, the generated ROS also promotes copper releaseto strengthen cuproptosis, and eventually improves tumor thermotherapy inturn. In general, DMMA@Cu_(2-x)Se with sequentially triggered copper-release,efficient cuproptosis, and appropriate photothermal is a self-enhanced nanoplatformfor cuproptosis-driven enhancement of thermotherapy.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号